49O - Downregulation of USP28 confers poorer overall survival to melanoma patients and causes resistance to RAF inhibitors

Date 05 March 2018
Event TAT 2018 - Targeted Anticancer Therapies
Session Proffered Paper Session 1
Topics Cancer Immunology and Immunotherapy
Melanoma and other Skin Tumours
Presenter Azad Saei
Citation Annals of Oncology (2018) 29 (suppl_3): iii7-iii9. 10.1093/annonc/mdy048
Authors A. Saei1, M. Palafox2, T. Benoukraf3, N. Kumari4, P. Iyengar3, Z.F. Bin Adam Isa3, H. Yang3, W.L. Tam1, V. Serra2, P. Eichhorn3
  • 1Genome Institute of Singapore, A*STAR, 138672 - Singapore/SG
  • 2Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, 08035 - Barcelona/ES
  • 3Cancer Science Institute of Singapore, 117599 - Singapore/SG
  • 4Biochemistry, National University of Singapore, 119228 - Singapore/SG

Abstract